Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Value of FDG PET/CT for the restaging of colorectal cancer after treatment with Erbitux. Mittra, E., Iagaru, A., Kunz, P., Quon, A., Gambhir, S. SOC NUCLEAR MEDICINE INC. 2009
View details for Web of Science ID 000444145702017